top of page
Commercialization Symposium on
Entrepreneurship, Therapeutic Discovery and Technological Development
Dec 8, 2023, 9:00am – 12:30pm followed by networking session 12:30-2:00pm
Charles K. Kao Auditorium, Hong Kong Science and Technology Park
Welcome to COI's inaugural Commercialization Symposium, where we will showcase the latest developments in therapeutic discovery and entrepreneurship from both local and international healthcare perspectives. Our engaging sessions will provide valuable insights into cutting-edge advancements in scientific research translation, intellectual property, and industrial partnerships, all through the eyes of our distinguished innovators and experts in the field. Join us for an enlightening experience that promises to make a lasting impact on the healthcare landscape.
Speakers
Agenda
9:00AM-9:30AM
Check-in and Welcome Reception
9:30AM-9:40AM
Welcome Remarks
Albert Wong, Chief Executive Officer, Hong Kong Science and Technology Parks Corporation
9:40AM-10:10AM
Keynote Presentation
Tak Mak, Ph.D. | A New Era of Immunology and Impact
10:15AM-11:20AM
Flash Talks
Anskar Leung, M.D., Ph.D. | A cost effective strategy for high-throughput drug discovery - the zebrafish perspective
Alan Wong, Ph.D. | Perfecting CRISPR technology for applications
Naoto Hirano, M.D., Ph.D. | New generation of T cell-based immunotherapies
Alfred Tan, Ph.D. | Preparing research for better IP protection and successful commercialisation
11:20AM-12:20PM
Panel Discussion 1:
Life Science Entrepreneurship: A Scientist’s Perspective on Transforming Inventions into Innovations (Panel moderator: Dr. Steven Chan)
Anskar Leung, M.D., Ph.D. | Founder, ZeBlast Technology Ltd
Alan Wong, Ph.D. | Project Leader, Centre for Oncology and Immunology Ltd
Naoto Hirano, M.D., Ph.D. | Senior Scientist, University Health Network
Panel Discussion 2:
The Key Elements in the Path towards Commercialization: IP, Partnership, and Funding (Panel moderator: Prof. Anskar Leung)
Alfred Tan, Ph.D. | Deputy Director, Technology Transfer Office - The University of Hong Kong
Tony Cheng, EMBA | General Manager, Merck KGaA
Karen Liu, EMBA, Ph.D. | Founding Partner, 3E Bioventures
12:20PM-12:25PM
Closing Remarks
Suet-Yi Leung, M.D. | Managing Director, Centre for Oncology and Immunology
12:30PM-2:00PM
Networking Session
Light refreshments will be provided.
Co-Organised By
Supported by
Diamond Sponsors
Platinum Sponsors
Gold Sponsor
© 2023 by Centre for Oncology and Immunology
bottom of page